HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylvia Metz-Schimmerl Selected Research

Aftercare (After-Treatment)

9/2005Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylvia Metz-Schimmerl Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
01/2009 - 08/2005
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2013
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2005
1Insulin Resistance
08/2005

Drug/Important Bio-Agent (IBA)

1Thromboplastin (Tissue Factor)IBA
03/2013
1Biomarkers (Surrogate Marker)IBA
03/2013
1Thalidomide (Thalomid)FDA Link
09/2005
1Blood Glucose (Blood Sugar)IBA
08/2005

Therapy/Procedure

2Resistance Training
01/2009 - 08/2005
1Aftercare (After-Treatment)
09/2005
1Endurance Training
08/2005